vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and Ohmyhome Ltd (OMH). Click either name above to swap in a different company.

Ohmyhome Ltd is the larger business by last-quarter revenue ($5.2M vs $2.8M, roughly 1.9× DBV Technologies S.A.). Ohmyhome Ltd runs the higher net margin — -32.6% vs -1195.5%, a 1162.9% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs 58.1%). Ohmyhome Ltd produced more free cash flow last quarter ($-599.2K vs $-32.6M).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Ohmyhome Ltd is a leading Southeast Asian proptech firm offering end-to-end residential property services including home sales, rentals, mortgage advisory, and conveyancing solutions. Operating primarily in Singapore and Malaysia, it connects property owners, prospective buyers, tenants, and licensed agents to streamline real estate transactions for all user groups.

DBVT vs OMH — Head-to-Head

Bigger by revenue
OMH
OMH
1.9× larger
OMH
$5.2M
$2.8M
DBVT
Growing faster (revenue YoY)
DBVT
DBVT
+100.6% gap
DBVT
158.8%
58.1%
OMH
Higher net margin
OMH
OMH
1162.9% more per $
OMH
-32.6%
-1195.5%
DBVT
More free cash flow
OMH
OMH
$32.0M more FCF
OMH
$-599.2K
$-32.6M
DBVT

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
DBVT
DBVT
OMH
OMH
Revenue
$2.8M
$5.2M
Net Profit
$-33.2M
$-1.7M
Gross Margin
31.4%
Operating Margin
-1235.7%
-26.1%
Net Margin
-1195.5%
-32.6%
Revenue YoY
158.8%
58.1%
Net Profit YoY
-8.9%
-1.1%
EPS (diluted)
$-0.24
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
OMH
OMH
Q3 25
$2.8M
Q2 25
$1.5M
$5.2M
Q2 24
$1.2M
$3.3M
Q1 24
$1.4M
Q4 23
$8.9M
Q3 23
$2.4M
Q2 23
$2.3M
Q1 23
$2.2M
Net Profit
DBVT
DBVT
OMH
OMH
Q3 25
$-33.2M
Q2 25
$-41.9M
$-1.7M
Q2 24
$-33.1M
$-1.7M
Q1 24
$-27.3M
Q4 23
$134.3M
Q3 23
$-16.7M
Q2 23
$-24.2M
Q1 23
$-20.6M
Gross Margin
DBVT
DBVT
OMH
OMH
Q3 25
Q2 25
31.4%
Q2 24
37.4%
Q1 24
Q4 23
Q3 23
Q2 23
Q1 23
Operating Margin
DBVT
DBVT
OMH
OMH
Q3 25
-1235.7%
Q2 25
-2806.2%
-26.1%
Q2 24
-2914.9%
-61.0%
Q1 24
-2029.7%
Q4 23
-134.3%
Q3 23
-770.2%
Q2 23
-1096.0%
Q1 23
-964.7%
Net Margin
DBVT
DBVT
OMH
OMH
Q3 25
-1195.5%
Q2 25
-2858.4%
-32.6%
Q2 24
-2852.4%
-51.0%
Q1 24
-1943.5%
Q4 23
1512.8%
Q3 23
-705.6%
Q2 23
-1059.6%
Q1 23
-937.1%
EPS (diluted)
DBVT
DBVT
OMH
OMH
Q3 25
$-0.24
Q2 25
$-0.31
$-0.07
Q2 24
$-0.34
$-0.07
Q1 24
$-0.28
Q4 23
$-0.11
Q3 23
$-0.17
Q2 23
$-0.26
Q1 23
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
OMH
OMH
Cash + ST InvestmentsLiquidity on hand
$69.8M
$4.9M
Total DebtLower is stronger
$379.0K
Stockholders' EquityBook value
$52.9M
$6.7M
Total Assets
$110.5M
$9.6M
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
OMH
OMH
Q3 25
$69.8M
Q2 25
$103.2M
$4.9M
Q2 24
$66.2M
$1.8M
Q1 24
$101.5M
Q4 23
$141.4M
Q3 23
$149.1M
Q2 23
$174.0M
Q1 23
$192.3M
Total Debt
DBVT
DBVT
OMH
OMH
Q3 25
Q2 25
$379.0K
Q2 24
$607.6K
Q1 24
Q4 23
Q3 23
Q2 23
Q1 23
Stockholders' Equity
DBVT
DBVT
OMH
OMH
Q3 25
$52.9M
Q2 25
$86.2M
$6.7M
Q2 24
$79.1M
$5.4M
Q1 24
$111.7M
Q4 23
$140.2M
Q3 23
$144.0M
Q2 23
$164.2M
Q1 23
$179.1M
Total Assets
DBVT
DBVT
OMH
OMH
Q3 25
$110.5M
Q2 25
$143.4M
$9.6M
Q2 24
$114.2M
$9.4M
Q1 24
$145.9M
Q4 23
$183.0M
Q3 23
$189.8M
Q2 23
$217.5M
Q1 23
$232.9M
Debt / Equity
DBVT
DBVT
OMH
OMH
Q3 25
Q2 25
0.06×
Q2 24
0.11×
Q1 24
Q4 23
Q3 23
Q2 23
Q1 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
OMH
OMH
Operating Cash FlowLast quarter
$-32.4M
$-496.2K
Free Cash FlowOCF − Capex
$-32.6M
$-599.2K
FCF MarginFCF / Revenue
-1173.5%
-11.5%
Capex IntensityCapex / Revenue
4.2%
2.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-138.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
OMH
OMH
Q3 25
$-32.4M
Q2 25
$-33.9M
$-496.2K
Q2 24
$-35.1M
$-1.5M
Q1 24
$-34.7M
Q4 23
$-13.7M
Q3 23
$-19.6M
Q2 23
$-25.6M
Q1 23
$-20.8M
Free Cash Flow
DBVT
DBVT
OMH
OMH
Q3 25
$-32.6M
Q2 25
$-33.9M
$-599.2K
Q2 24
$-35.8M
$-1.5M
Q1 24
$-36.0M
Q4 23
$-14.0M
Q3 23
$-19.6M
Q2 23
$-25.7M
Q1 23
$-21.0M
FCF Margin
DBVT
DBVT
OMH
OMH
Q3 25
-1173.5%
Q2 25
-2316.5%
-11.5%
Q2 24
-3084.0%
-45.8%
Q1 24
-2560.6%
Q4 23
-158.2%
Q3 23
-827.3%
Q2 23
-1124.0%
Q1 23
-955.0%
Capex Intensity
DBVT
DBVT
OMH
OMH
Q3 25
4.2%
Q2 25
2.2%
2.0%
Q2 24
63.0%
0.4%
Q1 24
94.9%
Q4 23
4.0%
Q3 23
2.1%
Q2 23
7.2%
Q1 23
5.1%
Cash Conversion
DBVT
DBVT
OMH
OMH
Q3 25
Q2 25
Q2 24
Q1 24
Q4 23
-0.10×
Q3 23
Q2 23
Q1 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons